BTG4 and adrenal cortex carcinoma: However, the BTG3 and BTG4 increased mainly correlated with survival disadvantages, where BTG3 predicted poor prognosis for ACC, HNSC, LGG, and BTG4 predicted poor prognosis for HNSC, KIRC, MESO, UCS (Supplement Fig. 1; Table S2).